Change in number of shares and votes in Vitrolife AB (publ)
On December 30, 2021, Vitrolife AB announced the issuance of 17,251,312 new shares following a decision made at the Extraordinary General Meeting on October 20, 2021. This increase brings the total number of shares to 135,447,190 as of the announcement date. This change is part of the company's compliance with the Swedish Financial Instruments Trading Act and aims to enhance liquidity and shareholder value.
- Issuance of 17,251,312 new shares could enhance liquidity in the market.
- Total shares increased to 135,447,190, potentially improving shareholder engagement.
- Share issuance may dilute existing shareholder value.
GÖTEBORG, Sweden, Dec. 30, 2021 /PRNewswire/ -- In accordance with the decision at the Extraordinary General Meeting on 20 October 2021, Vitrolife AB has issued a total of 17,251,312 new shares. As of 30 December 2021, following the new issue of shares, the number of shares and votes in Vitrolife AB (publ) amounts to 135,447,190.
Gothenburg, December 30, 2021
VITROLIFE AB (publ)
Thomas Axelsson, CEO
CONTACT:
Queries should be addressed to:
Thomas Axelsson, CEO, tel 46 31 721 80 01
Mikael Engblom, CFO, tel 46 31 721 80 14
This information is information that Vitrolife AB is obliged to make public pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 5.30 pm CET on December 30, 2021.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Press release |
View original content:https://www.prnewswire.com/news-releases/change-in-number-of-shares-and-votes-in-vitrolife-ab-publ-301451946.html
SOURCE Vitrolife AB (publ)
FAQ
What is the date of the Vitrolife AB share issuance announcement?
How many new shares were issued by Vitrolife AB?
What is the total number of shares outstanding for Vitrolife AB after the new issuance?